ArticleNeuro-oncology advances

Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors.

Tessa O House et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.